1-11 of 11 results for subject:"Muscular dystrophy"
Librarians' tools
- Search time
- 0.202 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"Muscular dystrophy"
- We searched for
- subject_t:"Muscular dystrophy" OR subject_t:"Duchenne muscular dystrophy" OR subject_t:"Myotonic dystrophy" OR subject_ses:11775
Type
House
Session
Month
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health, if she will take steps to increase the funding for research to find treatments for Duchenne Muscular Dystrophy; and if she will make a statement.
To ask the Secretary of State for Health, if she will take steps to increase the funding for research to find treatments for Duchenne Muscular Dystrophy; and if she will make a statement.
To ask the Secretary of State for Health what research she has commissioned on the (a) physical causes and (b) treatment of Duchenne muscular dystrophy; how much public funding has been spent on such research in each of the last five years; and if she will make a statement.
To ask the Secretary of State for Health what research she has commissioned on the (a) physical causes and (b) treatment of Duchenne muscular dystrophy; how much public funding has been spent on such research in each of the last five years; and if she will make a statement.
To ask the Secretary of State for Health what funding has been made available for research into Duchenne muscular dystrophy in each year since 1997 from (a) the Medical Research Council, (b) the Department of Health's research and development budget and (c) other sources; what research funding she plans to...
To ask the Secretary of State for Health what funding has been made available for research into Duchenne muscular dystrophy in each year since 1997 from (a) the Medical Research Council, (b) the Department of Health's research and development budget and (c) other sources; what research funding she plans to...
| £ million | |
| Spend | |
| 1997–98 | 0.5 |
| 1998–99 | 0.53 |
| 1999–2000 | 0.59 |
| 2000–01 | 1.13 |
| 2001–02 | 2 |
| 2002–03 | 1.8 |
| 2003–04 | 2.4 |
I am delighted to hear that we finally have a date for the Identity Cards Bill. We look forward to what will no doubt be a vigorous debate. Will the Leader of the House give us, as a matter of urgency, an opportunity to discuss the Home Secretary's decision to...
I am delighted to hear that we finally have a date for the Identity Cards Bill. We look forward to what will no doubt be a vigorous debate. Will the Leader of the House give us, as a matter of urgency, an opportunity to discuss the Home Secretary's decision to...
Over the past few weeks I have become used to being grateful for the kind observations emanating from the Opposition Front Bench, not least in relation to identity cards. I am sure that Labour Members look forward to discovering what precisely is the Opposition's position on that important issue. When...
Over the past few weeks I have become used to being grateful for the kind observations emanating from the Opposition Front Bench, not least in relation to identity cards. I am sure that Labour Members look forward to discovering what precisely is the Opposition's position on that important issue. When...
That this House recognises that on average two young people die every week in the UK from the genetic severe muscle wasting disease Duchenne muscular dystrophy (DMD); congratulates the Department of Health for its initiative in providing ??1.6 million to establish the MDEX consortium of researchers to start the first phase of a clinical trial in the UK for a gene therapy for DMD; and calls upon the Secretary of State for Health to support the aims of the Race Against Time Campaign organised by Parent Project UK, the Muscular Dystrophy Campaign and the Duchenne Family Support Group to provide ??20 million of further funding to accelerate the MDEX project and other research towards a cure or treatment for this devastating disease.
That this House recognises that on average two young people die every week in the UK from the genetic severe muscle wasting disease Duchenne muscular dystrophy (DMD); congratulates the Department of Health for its initiative in providing ??1.6 million to establish the MDEX consortium of researchers to start the first...
To ask the Secretary of State for Health, what assessment her Department has made of the clinical trials being carried out in the development of a treatment for Duchenne muscular dystrophy; and if she will make a statement.
To ask the Secretary of State for Health, what assessment her Department has made of the clinical trials being carried out in the development of a treatment for Duchenne muscular dystrophy; and if she will make a statement.
To ask the Secretary of State for Health, what research her Department has commissioned into developing a therapy for Duchenne muscular dystrophy; and if she will make a statement.
To ask the Secretary of State for Health, what research her Department has commissioned into developing a therapy for Duchenne muscular dystrophy; and if she will make a statement.
To ask the Secretary of State for Health, how much funding her Department has committed for research into Duchenne muscular dystrophy in 2005-06.
To ask the Secretary of State for Health, how much funding her Department has committed for research into Duchenne muscular dystrophy in 2005-06.
To ask the Secretary of State for Health, if he will increase funding available for research into developing a therapy for Duchenne muscular dystrophy; and if he will make a statement.
To ask the Secretary of State for Health, if he will increase funding available for research into developing a therapy for Duchenne muscular dystrophy; and if he will make a statement.